MedTrace Logo

Dexamethasone-induced Hiccup in Chemotherapy Patients Treated by Methylprednisolone Rotation

NCT01974024 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2017-04-28

No results posted yet for this study

Summary

The aims of this study were to investigate the feasibility of methylprednisolone rotation as treatment of DIH.

Conditions

  • Dexamethasone-induced Hiccup in Chemotherapy

Interventions

DRUG

methylprednisolone

Adult patients who experienced DIH within 3 days after the administration of dexamethasone as an antiemetic were screened. Eligible patients were randomly assigned to receive dexamethasone or methylprednisolone as an antiemetic (randomization phase). In the next cycle of chemotherapy, the dexamethasone group received methylprednisolone and vice versa in the methylprednisolone group (crossover phase).

Sponsors & Collaborators

  • Gyeongsang National University Hospital

    collaborator OTHER

  • Dong-A University Hospital

    collaborator OTHER

  • Samsung Medical Center

    collaborator OTHER

  • Chung-Ang University

    lead OTHER

Principal Investigators

  • Jung Hun Kang, M.D. · Gyeongsang National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-01
Primary Completion
2016-06-30
Completion
2016-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01974024 on ClinicalTrials.gov